Literature DB >> 25016371

New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni.

Stefano Guglielmo1, Daniela Cortese2, Francesca Vottero1, Barbara Rolando1, Valerie P Kommer3, David L Williams4, Roberta Fruttero5, Alberto Gasco1.   

Abstract

A series of NO-donor praziquantel hybrid compounds was obtained by combining praziquantel (PZQ) and furoxan moieties in a single entity. NO-donor properties of the furoxan derivatives were evaluated by detecting nitrite after incubation of the products in 7.4 pH buffered solution in the presence of L-cysteine. Structurally-related furazans, devoid of NO release capacity, were also synthesized for control purposes. All products were studied for their ability to inhibit recombinant Schistosoma mansoni thioredoxin glutathione reductase (TGR). Mobility and death of adult Schistosoma mansoni worms cultured in the presence of the products were evaluated versus PZQ. Analysis of the results showed that some products were endowed with both PZQ and NO-dependent antiparasitic properties. Compounds 6, 7, 18, and 24 emerged as the most interesting balanced hybrids, worthy of additional study on PZQ-resistant parasites.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Furoxans; NO-donor praziquantel; Praziquantel; Schistosomiasis; Thioredoxin glutathione reductase

Mesh:

Substances:

Year:  2014        PMID: 25016371      PMCID: PMC4160910          DOI: 10.1016/j.ejmech.2014.07.007

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  27 in total

Review 1.  Molecular bases for the anti-parasitic effect of NO (Review).

Authors:  Marco Colasanti; Luigi Gradoni; Marco Mattu; Tiziana Persichini; Luca Salvati; Giorgio Venturini; Paolo Ascenzi
Journal:  Int J Mol Med       Date:  2002-02       Impact factor: 4.101

Review 2.  Praziquantel and schistosomiasis.

Authors:  Alexander Dömling; Kareem Khoury
Journal:  ChemMedChem       Date:  2010-09-03       Impact factor: 3.466

3.  Investigation of the phase diagrams of chiral praziquantel.

Authors:  Yue Liu; Xin Wang; Jing-Kang Wang; Chi Bun Ching
Journal:  Chirality       Date:  2006-05-05       Impact factor: 2.437

4.  Nitric oxide donor doxorubicins accumulate into Doxorubicin-resistant human colon cancer cells inducing cytotoxicity.

Authors:  Konstantin Chegaev; Chiara Riganti; Loretta Lazzarato; Barbara Rolando; Stefano Guglielmo; Ivana Campia; Roberta Fruttero; Amalia Bosia; Alberto Gasco
Journal:  ACS Med Chem Lett       Date:  2011-04-04       Impact factor: 4.345

5.  Studies on agents with mixed NO-dependent vasodilating and beta-blocking activities.

Authors:  D Boschi; A Di Stilo; C Cena; M Lolli; R Fruttero; A Gasco
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

6.  Molecular and enzymatic characterisation of Schistosoma mansoni thioredoxin.

Authors:  Heather M Alger; Ahmed A Sayed; Miguel J Stadecker; David L Williams
Journal:  Int J Parasitol       Date:  2002-09       Impact factor: 3.981

7.  New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.

Authors:  A Di Stilo; S Visentin; C Cena; A M Gasco; G Ermondi; A Gasco
Journal:  J Med Chem       Date:  1998-12-31       Impact factor: 7.446

8.  Nitrates and NO-NSAIDs in cancer chemoprevention and therapy: in vitro evidence querying the NO donor functionality.

Authors:  Tareisha Dunlap; Samer O Abdul-Hay; R Esala P Chandrasena; Ghenet K Hagos; Vaishali Sinha; Zhiqiang Wang; Huali Wang; Gregory R J Thatcher
Journal:  Nitric Oxide       Date:  2008-04-23       Impact factor: 4.427

9.  Towards an understanding of the mechanism of action of praziquantel.

Authors:  Anthony D Aragon; Reza A Imani; Vint R Blackburn; Pauline M Cupit; Sandra D Melman; Tinopiwa Goronga; Thomas Webb; Eric S Loker; Charles Cunningham
Journal:  Mol Biochem Parasitol       Date:  2008-11-28       Impact factor: 1.759

10.  Praziquantel, a new board-spectrum antischistosomal agent.

Authors:  R Gönnert; P Andrews
Journal:  Z Parasitenkd       Date:  1977-07-21
View more
  7 in total

Review 1.  Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.

Authors:  Nuno Vale; Maria João Gouveia; Gabriel Rinaldi; Paul J Brindley; Fátima Gärtner; José M Correia da Costa
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

2.  Radicicol, a Novel Lead Compound against the Migratory-Stage Schistosomula of Schistosoma japonicum.

Authors:  Liangxiong Xu; Qiuli Liu; Qingren Zeng; Ping Wu; Quan Yu; Kongzhen Gu; Jinghua Xue; Xiaoyi Wei
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

3.  Something old, something new: is praziquantel enough for schistosomiasis control?

Authors:  W Evan Secor; Susan P Montgomery
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

4.  A Machine Learning Strategy for Drug Discovery Identifies Anti-Schistosomal Small Molecules.

Authors:  Kimberley M Zorn; Shengxi Sun; Cecelia L McConnon; Kelley Ma; Eric K Chen; Daniel H Foil; Thomas R Lane; Lawrence J Liu; Nelly El-Sakkary; Danielle E Skinner; Sean Ekins; Conor R Caffrey
Journal:  ACS Infect Dis       Date:  2021-01-12       Impact factor: 5.084

5.  Brønsted acid-mediated cyclization-dehydrosulfonylation/reduction sequences: An easy access to pyrazinoisoquinolines and pyridopyrazines.

Authors:  Ramana Sreenivasa Rao; Chinnasamy Ramaraj Ramanathan
Journal:  Beilstein J Org Chem       Date:  2017-03-07       Impact factor: 2.883

Review 6.  Medicinal chemistry perspectives of 1,2,3,4-tetrahydroisoquinoline analogs - biological activities and SAR studies.

Authors:  Banoth Karan Kumar; Kondapalli Venkata Gowri Chandra Sekhar; Subhash Chander; Selvaraj Kunjiappan; Sankaranarayanan Murugesan
Journal:  RSC Adv       Date:  2021-03-29       Impact factor: 4.036

7.  Nitric oxide debilitates the neuropathogenic schistosome Trichobilharzia regenti in mice, partly by inhibiting its vital peptidases.

Authors:  Tomáš Macháček; Barbora Šmídová; Jan Pankrác; Martin Majer; Jana Bulantová; Petr Horák
Journal:  Parasit Vectors       Date:  2020-08-20       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.